Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial

Overview of attention for article published in High Blood Pressure & Cardiovascular Prevention, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 258)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 2 X users
patent: 4 patents

facebook: 1 Facebook page
video: 1 YouTube creator

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 111 Mendeley

Summary X Patents Facebook YouTube Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

COMPOSTO NUTRACEUTICO PER IL TRATTAMENTO DELL'ECCESSO DI ACIDO URICO

Application IT-UA20162896-A1

Italy

ORAL FORMULATION COMPRISING BERBERINE AND MORUS ALBA EXTRACT

Application WO-2017008909-A1

World Intellectual Property Organisation (WIPO)

ORAL FORMULATION COMPRISING BERBERINE AND MORUS ALBA EXTRACT

Application EP-3117825-A1

European Patent Office

NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS WEIGHT AND MODERATE…

Application EP-3025593-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.